Anthem Biosciences to Launch INR 3,395 Cr IPO on July 14

The issue, an offer-for-sale by existing shareholders, will carry a price band of INR 540 to INR 570 per equity share of face value INR 2. Anchor Investor bidding will open on July 11.

Bengaluru-based Anthem Biosciences is set to open its INR 3,395 Cr Initial Public Offering (IPO) on Monday, July 14, 2025.

The issue, an offer-for-sale by existing shareholders, will carry a price band of INR 540 to INR 570 per equity share of face value INR 2. Anchor Investor bidding will open on July 11.

Founded in 2006, Anthem Biosciences is a Contract Research, Development, and Manufacturing Organization (CRDMO) offering specialized fermentation-based APIs such as probiotics, peptides, enzymes, and biosimilars. It operates three cGMP-compliant manufacturing facilities and serves over 550 clients in 44 countries.

The IPO will reserve shares for qualified institutional buyers (QIBs), retail investors, and employees, in line with SEBI regulations.JM Financial, Citigroup Global Markets India, JP Morgan India, and Nomura are the book-running lead managers.

Stay tuned for more such updates on Digital Health News